MARKET LEADERS, BUILDING A HEALTHIER SOCIETY!
Our pharmaceutical company owns more than 50% of the Lithuanian parallel drug import market. In addition to importing prescription drugs, we also supply orphan drugs.
Our pharmaceutical company owns more than 50% of the Lithuanian parallel drug import market.
We always get the newest information about the prices of medicines in different countries, that’s why we supply the medication at the lowest price.
We usually provide drugs with a total shelf life of at least 60-75% for testing, and a maximum of 1-2 batches. We assure serialization and validity requirements.
Our goal is to become a long-term, reliable partner, so we value our partners’ trust and make all decisions with the utmost responsibility.